Safety and Efficacy of Botulinum Toxin Type A (BOTOX) to Treat Chronic Migraine in Korea
Latest Information Update: 09 May 2019
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- Sponsors Allergan
- 07 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Oct 2014 Planned End Date changed from 1 May 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
- 29 Oct 2014 Planned primary completion date changed from 1 May 2015 to 1 Apr 2015 as repoted by ClinicalTrials.gov record.